Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
12 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
MENTANA DX from Evergem, company number BE0786290908, closed financial year 2025 with a result of € -31,505 after tax. For that financial year MENTANA DX recorded a gross margin of € -33,226 and equity of € 228,548. Compared with financial year 2024, the result moved from € -35,144 to € -31,505. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 228,548
▼ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -31,505
▲ 10 % less loss than in 2024
Profit after tax over the fiscal year.
€ 3,274
▼ 99% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -71,452.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,450
▼ 78% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -4,665 | € -34,876 | € -33,226 | ▲ € 1,650 |
| Profit after taxes | € -4,802 | € -35,144 | € -31,505 | ▲ € 3,639 |
| Equity | € 295,198 | € 260,053 | € 228,548 | ▼ 12% |
| Total debts | € 0 | € 6,633 | € 1,450 | ▼ 78% |
| Cash | € 295,197 | € 266,686 | € 3,274 | ▼ 99% |
| Retained profit | € -4,802 | € -39,947 | € -71,452 | ▼ € 31,505 |
| Balance sheet total | € 295,198 | € 266,686 | € 229,998 | ▼ 14% |
Key figures of MENTANA DX, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MENTANA DX?
What happened at MENTANA DX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 31,505. Source: NBB ↗
- New establishment in Evergem. KBO
- Start of the company according to the CBE. KBO
- Post Verba Verbera NV became a director. NBB
In short
From € 4,802 loss in 2023 to € 31,505 loss in 2025.
Management
The stake of POST VERBA VERBERA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
MENTANA DXBehind MENTANA DX is Post Verba Verbera NV. The shares are held by POST VERBA VERBERA (100%).
Directors
According to the 2025 annual accounts
Director · represented by Margareta Nuytinck
Also active at: LABORATORIUM M. NUYTINCK, LABO VOOR KLINISCHE BIOLOGIE, ANABIOTEC, OHMX.bio, Ziphius
since 2022
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Noorwegenstraat 4
9940 Evergem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.
All companies at this address →LABORATORIUM M. NUYTINCK same network
€ 24.5 million revenue · 2025
LABO VOOR KLINISCHE BIOLOGIE same network
€ 3.6 million gross margin · 2025
POST VERBA VERBERA same network
€ 4.5 million revenue · 2025
ANABIOTEC same network
€ 9 million gross margin · 2025
Group Nuytinck
+7 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0786.290.908
- VAT number
- BE 0786.290.908
- Registered office
- Noorwegenstraat 4, 9940 Evergem
- Names & denominations
- MENTANA DX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 May 2022
- Peppol
- Not registered
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Vervaardiging van overige farmaceutische producten
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Vervaardiging van geneesmiddelen
Vervaardiging van farmaceutische grondstoffen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige gespecialiseerde wetenschappelijke en technische activiteiten